Abstract
Introduction
Most experts still regard transurethral resection of the prostate (TURP) as the surgical 'golden standard' treatment for benign prostatic hyperplasia (BPH). However, a considerably high morbidity rate of 18% has persisted over the last decades [1] . Intraoperative bleeding is one of the major complications of TURP and has led to a search of various alternative methods of prostatic tissue ablation [2] [3] [4] [5] [6] , which primarily were sought to provide better hemostasis. Of these methods, the different laser procedures [2] [3] [4] and the more recently introduced vaporization techniques [5] are used most frequently today.
In 1996, we introduced a newly designed resection loop, the so-called Band Electrode ( fig. 1 ) and reported preliminary results on the first 30 patients [7] . Herein, we report our immediate and midterm results of 265 men treated with this device at our institution. To our knowledge, this study represents the largest series of patients undergoing TURP with the Band Electrode for the treatment of lower urinary tract symptoms on the basis of BPH.
Materials and Methods
In a single-center study, we prospectively analyzed 265 consecutive patients with moderate to severe prostatism on the basis of BPH who underwent transurethral resection of the prostate with the Band Electrode (Olympus, Winter & Ibe GmbH, Hamburg, Germany) from November 1996 to June 1999. The operations were performed by two surgeons. The average age of the patients was 72.3 (54-87) years. Preoperatively, 38 of these men had indwelling catheters because of urinary retention. The median prostate volume measured by transrectal ultrasound (TRUS) was 42 (16-115) ml preoperatively. Voiding function was evaluated pre-and postoperatively through International Prostate Symptom Score (IPSS) and Life Quality Index (L). Minimum criteria for TURP with the Band Electrode were urinary retention, a peak flow of less than 12 ml/s and/or urodynamic signs of obstruction. Diagnostic evaluation consisted of patient history, general physical examination, digital rectal examination, uroflowmetry, in selected cases urethrocystogram (suspicion of urethral stricture) and urodynamic examination (suspicion of neurogenic voiding disorder), ultrasound to determine prostate volume (transrectal) and postvoid residual (suprapubic) and finally laboratory evaluation including prostate-specific antigen.
As described above, the Band Electrode has a width of 1.2 mm, a thickness of 0.3 mm and a diameter of 7.0 mm (CH 27) ( fig. 1 ). This loop can be applied to any standard resectoscope. We used a 27 Fr double-sheath rotating continuous flow resectoscope (Olympus). Power was supplied by the ERBOTOM ICC 350 (ERBE Elektromedizin, Tübingen, Germany), a high-frequency (HF) generator which incorporates automatic voltage control (AutoCut) as well as automatic electric arc control (HighCut). In the HighCut setting the generator delivers a stronger vaporization effect. The system was set to both modes, depending on the intraoperative findings. The average power setting was 200 W. However, the unit delivers the precise power required for cutting, thus avoiding unnecessarily high power levels. This feature is not depending on resection speed and depth. The HF voltage, current and power have been recorded by a computerassisted device, especially designed for this evaluation. The TURP procedure was video-monitored by the Olympus Mini-Chip-Camera OTV S4 (Olympus).
Resection techniques with the Band Electrode differed in no way from those used with conventional wire loop electrodes. After initial resection of the middle lobe, the lateral lobes and the ventral region were resected clockwise from the bladder neck to the verumonta- Follow-up included IPSS, Life Quality Index (L), uroflowmetry and ultrasonic measurement of postvoid residual urine. Additionally, mass of resected tissue, resection time, catheterization time and hospital days were assessed. Intra-and postoperative blood loss and circulatory complications were evaluated by pre-and postoperative hemoglobin, hematocrit and serum sodium levels.
For statistical analysis, the two-tailed unpaired t test between the different variable parameters was utilized to study unpaired data.
Follow-up was conducted at 3 days (n = 265), 12 months (n = 194) and 24 months (n = 172) after surgery. The poor participation of patients at long-term follow-up with only 75% attendance at 12 months is in part due to the German health care system, which does not routinely cover postsurgical follow-up at our hospital.
Results
The results in efficacy parameters (table 1) were as follows: median IPSS decreased from 23 (range 15-35) preoperatively to 8 (3-16) and 9 (3-16) at 12 and 24 months after surgery, respectively (p ! 0.001). Likewise, Life Quality Index (L) dropped from 4 (2-6) to 2 (1-3) and 2 (1-4), respectively (p ! 0.001). As far as urodynamic changes are concerned, peak urine flow improved from None of the 265 patients required blood transfusions or showed clinical or laboratory signs of a TUR syndrome. Only 4 patients had to be recatheterized temporarily due to secondary hemorrhage.
Concerning ablation performance, the resected tissue, weighed instantly after TURP, averaged 25.4 (8-102) g. The mean resection time was 26.4 (7-75) min. This leads to an overall ablation rate of 0.96 g/min. Indwelling catheters were removed 32 (24-72) h postoperatively. Average stay following TURP was 3.2 (1-8) days. Regarding the latter, one has to keep in mind that in Germany, most TURP patients will spend more than 7 days in hospital.
Despite a 1.3 times higher power need, the total energy application in vivo was comparable to conventional TURP. For a typical single cut with a duration of more than 1 s, in vivo measurements of electrical parameters revealed a power need averaging 100 (85-130) W for the Band Electrode, compared to 75 (60-105) W for a standard TURP wire loop (factor 1.3-1.5). Figure 2 demon- strates the course of power (P) and energy (E) for both electrodes. To correctly interpret these data, it is essential to remember that the actual power need does not necessarily correspond to the power setting at the generator. On account of less electrode activations with the Band Electrode, the total application of energy was equivalent to standard TURP and averaged approximately 15,000 W (= Joule) cumulatively, or 500 W per resected gram of tissue. Despite the higher power application described above, histological studies were not adversely affected by thermal alterations of resected tissue. In our series, 6 patients were diagnosed for prostate cancer on the basis of TURP specimens.
The use of the wider Band Electrode does not lead to a reduction of the field of vision. The operation site can be judged as accurately and extensively as with the wire loop electrode.
Of the 194 patients available for follow-up at 12 months, 2 (1.0%) developed postoperative urethral strictures, which were successfully treated by urethrotomia interna. None of the patients to date needed reoperation for bleeding or recurrent voiding dysfunction. The complications are summarized in table 2.
Discussion
The use of the Band Electrode enables the surgeon to resect hyperplastic prostatic tissue as easily and cleanly as with the conventional wire loop. The same equipment and surgical techniques can be applied. However, the high-frequency generator used in our study permits to carry out the procedure in both, automatic voltage control mode (AutoCut) as well as automatic electric arc control mode (HighCut). With the AutoCut setting, the resection is performed similarly to conventional TURP, whereas the HighCut setting produces a more vaporization-like resection ('Vapo-TURP'). On account of these features, HighCut was used for the most part of the resection, whereas AutoCut was mainly employed for resection close to the apex. As mentioned above, the width of the metal band does not reduce the surgeon's vision. The resection chips obtained with the Band Electrode are approximately identical in size and shape to those harvested with conventional electrodes, since both loops have a diameter of 7 mm. Histological examination is not altered by thermal changes. This finding was recently confirmed in a study comparing conventional TURP and TURP with a wider electrode, very similar to the Band Electrode [8] .
Although our data represent preliminary results with a limited follow-up, the efficacy of the Band Electrode pro-Reich/Faul cedure seems to be equivalent to conventional TURP [1] . This, of course, had to be expected since both techniques are truly tissue-ablative and leave an identical prostatic cavity postoperatively. The subjective impression of considerably reduced intraoperative bleeding with the use of the Band Electrode is confirmed by the inessential decrease of serum sodium and hematocrit levels. The changes of 2.0 mmol/l and 4.1%, respectively, are comparable to those reported for Nd:YAG laser prostatectomies [9] or vaporization procedures [5] . However, it has to be added critically that these parameters depend heavily on infusion therapy. Conventional TURP in large series has reportedly been associated with bleeding requiring blood transfusion in 8.4%, clot retention in 3.3% and TUR syndrome in 2.1% [10, 11] . None of our 265 patients required transfusions or displayed signs of a TUR syndrome.
Both efficacy and safety parameters generated in our series are well congruent with results of other investigators, using analogous electrodes in smaller studies [12, 13] .
The basis for this superior hemostasis is given by the shape of the newly designed electrode. Like conventional wire loop electrodes, the band is approximately 0.3 mm thick, but its width is nearly 1.2 mm. The duration of electric current at the vessel being coagulated depends on the geometry and size of the electrode and on the speed of cutting. It is proportional to the width of the loop and reciprocal to the speed of cutting. The additional width of the Band Electrode results in a prolonged flow of current, especially into the decisive lateral parts of the prostatic tissue. Since hemostasis is also a function of conduction time, this produces a more effective coagulation of transected bleeding vessels. Every surgeon has experienced the phenomenon of reduced intraoperative bleeding of prostatic tissue when resecting very slowly. Enlarging the width of the electrode from 0.3 to 1.2 mm creates a fourfold increase in the duration of contact between the electrode and the transected vessels ( fig. 3) . Thus, in theory the hemostatic effect can therefore be amplified by a factor of four when the speed of resection is constant. Representing even larger surfaces, pure vaporization procedures with roller electrodes perform an even more efficient closure of vessels. However, due to their low ablation efficacy, significantly prolonged activations lead to a 5-10 times higher energy need per removed gram of tissue [14] .
Recording electrical parameters during TURP with the Band Electrode and a conventional loop showed that the increase of power and energy applied to the tissue and adherent structures correlates with the width of the electrode. In our studies the power need in the HighCut mode averaged approx. 100 W for the Band Electrode, compared to approx. 75 W for the wire loop, representing a 1.3 times higher power application ( fig. 2) . Concerning each single cut, this factor is also valid for energy application since energy is the product of power and time. Concerning the total energy application per TURP, the 1.3 times higher power need of the Band Electrode was totally compensated by a decreased need for selective coagulation of bleeding vessels.
Nevertheless, the new type of electrode is not capable of closing every vessel at resection speed. Larger vessels still have to be coagulated selectively. Due to their width this is performed more comfortably than with the wire loop. Remarkably, the risk of inadvertent tissue or capsule perforation is also considerably reduced because of the greater width of the new device.
Conclusions
In our experience, the Band Electrode represents an ideal synthesis of regular transurethral resection of the prostate (TURP) and the benefits of transurethral vaporization of the prostate (TUVP). Due to its new geometry, it combines conventional resection efficacy with a superior hemostasis. In this initial phase II study displaying outstanding efficacy as well as safety, we showed that the Band Electrode could play a substantial role in the ongoing effort to raise the golden standard of surgical BPH treatment.
However, definitive evaluation of this promising device will require longer follow-up on a larger patient collective. Therefore, randomized clinical trials in a multicenter setting should be initiated to prospectively compare the Band Electrode with conventional TURP and TUVP.
